Text Size

Drug Utilization Prevalence in a Pediatric Care Medical Center

This study has been completed.
Sponsor:
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT00550706
First received: October 29, 2007
Last updated: October 11, 2008
Last verified: August 2007
History of Changes
  Purpose

One year prospective analysis of drug utilization and prescription point prevalence of medications in a pediatric tertiary care university medical center. Off-label use of medications in the study population will be also registered.


Condition
Infectious Diseases
Metabolic Diseases
Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Drug Utilization Prevalence in a Pediatric Care Medical Center

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Descriptive use of medications [ Time Frame: One year ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 400
Study Start Date: October 2007
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
1Pediatric Dept A
Children's files from this department will be analysed once weekly and medication prescription data will be registered
2 Pediatric Dept B
Children's files from this department will be analysed once weekly and medication prescription data will be registered

  Eligibility

Ages Eligible for Study:   1 Month to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Admitted children for medical treatment in two different pediatric departments

Criteria

Inclusion Criteria:

  • All admitted children receiving at least one prescribed or OTC medication.

Exclusion Criteria:

  • All admitted children who do not get a prescribed or OTC medication.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00550706

Locations
Israel
Rambam Health Care Campus
Haifa, Israel, 31096
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Principal Investigator: Norberto Krivoy, MD Rambam Health Care Campus
  More Information

No publications provided

Responsible Party: Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT00550706     History of Changes
Other Study ID Numbers: PDU2724_CTIL
Study First Received: October 29, 2007
Last Updated: October 11, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Rambam Health Care Campus:
Prescription point prevalence
Drug utilization
Define Daily Dose

Additional relevant MeSH terms:
Communicable Diseases
Infection
Metabolic Diseases

ClinicalTrials.gov processed this record on May 21, 2013